Neuro-oncology Archives - Insights Get the latest news and education from Mayo Clinic Laboratories Wed, 08 Oct 2025 16:49:49 +0000 en-US hourly 1 https://wordpress.org/?v=6.9 Defying all odds and exploring a remarkable journey beyond diagnosis: Mike Knudson https://news.mayocliniclabs.com/2023/10/09/defying-all-odds-and-exploring-a-remarkable-journey-beyond-diagnosis-mike-knudson/ https://news.mayocliniclabs.com/2023/10/09/defying-all-odds-and-exploring-a-remarkable-journey-beyond-diagnosis-mike-knudson/#respond Mon, 09 Oct 2023 13:00:00 +0000 https://news.mayocliniclabs.com/?p=103537 Defying all odds and exploring a remarkable journey beyond diagnosis: Mike KnudsonIn August of 2021, 28-year-old Mike Knudson, a Twin Cities resident known for his vibrant and active lifestyle, set out on what he anticipated to be an adventurous hiking vacation to the picturesque Glacier National Park in Montana. Little did he know that this journey in nature would be the start of an unexpected life path.

The post Defying all odds and exploring a remarkable journey beyond diagnosis: Mike Knudson appeared first on Insights.

]]> https://news.mayocliniclabs.com/2023/10/09/defying-all-odds-and-exploring-a-remarkable-journey-beyond-diagnosis-mike-knudson/feed/ 0 Chromosomal microarray better informs brain tumor diagnosis https://news.mayocliniclabs.com/2023/02/21/chromosomal-microarray-better-informs-brain-tumor-diagnosis/ https://news.mayocliniclabs.com/2023/02/21/chromosomal-microarray-better-informs-brain-tumor-diagnosis/#respond Tue, 21 Feb 2023 14:00:00 +0000 https://news.mayocliniclabs.com/?p=96995 Chromosomal microarray better informs brain tumor diagnosisMolecular biomarkers are a critical component in the treatment of adult and pediatric brain tumors. Robert Jenkins, M.D., Ph.D., explains how Mayo Clinic Laboratories' chromosomal microarray provides more comprehensive and accurate tumor analysis compared with other test methods.

The post Chromosomal microarray better informs brain tumor diagnosis appeared first on Insights.

]]> https://news.mayocliniclabs.com/2023/02/21/chromosomal-microarray-better-informs-brain-tumor-diagnosis/feed/ 0 New gene panel enhances brain tumor profiles https://news.mayocliniclabs.com/2023/01/31/new-gene-panel-enhances-brain-tumor-profiles-test-in-focus/ https://news.mayocliniclabs.com/2023/01/31/new-gene-panel-enhances-brain-tumor-profiles-test-in-focus/#respond Tue, 31 Jan 2023 14:00:00 +0000 https://news.mayocliniclabs.com/?p=94823 New gene panel enhances brain tumor profilesCristiane (Cris) Ida, M.D., explains how Mayo Clinic Laboratories' updated neuro-oncology gene panel provides more clinically relevant information for managing adult and pediatric brain tumors.

The post New gene panel enhances brain tumor profiles appeared first on Insights.

]]> https://news.mayocliniclabs.com/2023/01/31/new-gene-panel-enhances-brain-tumor-profiles-test-in-focus/feed/ 0 Neuro-oncology: An integrated approach to interpreting genetic information from brain tumor samples  https://news.mayocliniclabs.com/2023/01/02/neuro-oncology-an-integrated-approach-to-interpreting-genetic-information-from-brain-tumor-samples/ https://news.mayocliniclabs.com/2023/01/02/neuro-oncology-an-integrated-approach-to-interpreting-genetic-information-from-brain-tumor-samples/#respond Mon, 02 Jan 2023 14:00:00 +0000 https://news.mayocliniclabs.com/?p=95408 Neuro-oncology: An integrated approach to interpreting genetic information from brain tumor samples As part of Mayo Clinic’s Neuro-Oncology practice, the Division of Laboratory Genetics and Genomics tests about 50 brain tumors a week, and upwards of 1,500 brain tumors a year from all over the world.

The post Neuro-oncology: An integrated approach to interpreting genetic information from brain tumor samples  appeared first on Insights.

]]> https://news.mayocliniclabs.com/2023/01/02/neuro-oncology-an-integrated-approach-to-interpreting-genetic-information-from-brain-tumor-samples/feed/ 0 Against the odds: Alex Kraatz https://news.mayocliniclabs.com/2022/07/11/against-the-odds-alex-kraatz/ https://news.mayocliniclabs.com/2022/07/11/against-the-odds-alex-kraatz/#respond Mon, 11 Jul 2022 13:00:00 +0000 https://news.mayocliniclabs.com/?p=88819 Against the odds: Alex KraatzAs a two-time brain tumor survivor, Alex Kraatz has been through more harrowing medical experiences in his 34 years than most people face in a lifetime. But Alex’s fighting spirit, coupled with precision laboratory testing and cutting-edge treatments, have propelled him forward, keeping him hopeful despite the odds.

The post Against the odds: Alex Kraatz appeared first on Insights.

]]> https://news.mayocliniclabs.com/2022/07/11/against-the-odds-alex-kraatz/feed/ 0 Kelch-like protein 11 autoantibodies: A novel biomarker of testicular cancer associated neurological autoimmunity https://news.mayocliniclabs.com/2021/07/22/kelch-like-protein-11-autoantibodies-a-novel-biomarker-testicular-cancer-associated-neurological-autoimmunity/ https://news.mayocliniclabs.com/2021/07/22/kelch-like-protein-11-autoantibodies-a-novel-biomarker-testicular-cancer-associated-neurological-autoimmunity/#respond Thu, 22 Jul 2021 06:00:00 +0000 https://news.mayocliniclabs.com/?p=77140 Kelch-like protein 11 autoantibodies: A novel biomarker of testicular cancer associated neurological autoimmunityThe discovery of Kelch like protein 11 (KLHL11) IgG as a specific biomarker of neurological autoimmunity associated testicular germ cell tumor.

The post Kelch-like protein 11 autoantibodies: A novel biomarker of testicular cancer associated neurological autoimmunity appeared first on Insights.

]]> https://news.mayocliniclabs.com/2021/07/22/kelch-like-protein-11-autoantibodies-a-novel-biomarker-testicular-cancer-associated-neurological-autoimmunity/feed/ 0 Transforming clinical practice and changing outcomes for brain tumor patients https://news.mayocliniclabs.com/2021/06/09/transforming-clinical-practice-and-changing-outcomes-for-brain-tumor-patients/ https://news.mayocliniclabs.com/2021/06/09/transforming-clinical-practice-and-changing-outcomes-for-brain-tumor-patients/#respond Wed, 09 Jun 2021 12:50:00 +0000 https://news.mayocliniclabs.com/?p=76740 Transforming clinical practice and changing outcomes for brain tumor patientsThe genetic variability of glioma, and its more advanced relative glioblastoma, has made genetic testing to identify biomarkers associated with prognosis and treatment effectivity an integral component of care plan development. However, the acceleration of brain tumor research and discovery translates into an ever-changing testing environment.

The post Transforming clinical practice and changing outcomes for brain tumor patients appeared first on Insights.

]]> https://news.mayocliniclabs.com/2021/06/09/transforming-clinical-practice-and-changing-outcomes-for-brain-tumor-patients/feed/ 0 Practical aspects & pitfalls in molecular diagnosis of brain tumors https://news.mayocliniclabs.com/2021/01/13/practical-aspects-pitfalls-in-molecular-diagnosis-of-brain-tumors/ https://news.mayocliniclabs.com/2021/01/13/practical-aspects-pitfalls-in-molecular-diagnosis-of-brain-tumors/#respond Wed, 13 Jan 2021 13:30:00 +0000 https://news.mayocliniclabs.com/?p=70848 Practical aspects & pitfalls in molecular diagnosis of brain tumorsPractical aspects and pitfalls in the molecular diagnosis of brain tumors.

The post Practical aspects & pitfalls in molecular diagnosis of brain tumors appeared first on Insights.

]]> https://news.mayocliniclabs.com/2021/01/13/practical-aspects-pitfalls-in-molecular-diagnosis-of-brain-tumors/feed/ 0 Supporting Patient Care through Comprehensive Molecular and Cytogenetic Neuro-Oncology Testing https://news.mayocliniclabs.com/2020/02/13/neuro-oncology-testing-at-mayo-clinic/ https://news.mayocliniclabs.com/2020/02/13/neuro-oncology-testing-at-mayo-clinic/#respond Thu, 13 Feb 2020 15:00:00 +0000 https://news.mayocliniclabs.com/?p=45605 Supporting Patient Care through Comprehensive Molecular and Cytogenetic Neuro-Oncology TestingAt Mayo Clinic, we offer a comprehensive approach to testing that focuses on the best outcomes for the patient. Our testing method combines molecular and cytogenetic analysis (in addition to a standard morphological and histological assessment) to provide a clear picture of the diagnosis, prognosis, and treatment options. This approach maximizes the amount of information available, allowing for a tailored treatment plan.

The post Supporting Patient Care through Comprehensive Molecular and Cytogenetic Neuro-Oncology Testing appeared first on Insights.

]]> https://news.mayocliniclabs.com/2020/02/13/neuro-oncology-testing-at-mayo-clinic/feed/ 0 Pediatric neuro-oncology informative cases https://news.mayocliniclabs.com/2019/05/07/pediatric-neuro-oncology-informative-cases/ https://news.mayocliniclabs.com/2019/05/07/pediatric-neuro-oncology-informative-cases/#respond Tue, 07 May 2019 15:30:41 +0000 https://news.mayocliniclabs.com/?p=51019 Pediatric neuro-oncology informative casesNeuro-oncology is a complex field undergoing rapid changes with the advancement and evolution of sophisticated genetic testing. Evidence continues to grow in support of broad molecular and cytogenetic analysis for patients with brain tumors.

The post Pediatric neuro-oncology informative cases appeared first on Insights.

]]> https://news.mayocliniclabs.com/2019/05/07/pediatric-neuro-oncology-informative-cases/feed/ 0